English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Protein Kinase C zeta Interacts with a Novel Binding Region of G alpha q to Act as a Functional Effector

MPS-Authors
/persons/resource/persons224187

Sanchez-Fernandez,  Guzman
Pharmacology, Max Planck Institute for Heart and Lung Research, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Sanchez-Fernandez, G., Cabezudo, S., Caballero, A., Garcia-Hoz, C., Tall, G. G., Klett, J., et al. (2016). Protein Kinase C zeta Interacts with a Novel Binding Region of G alpha q to Act as a Functional Effector. JOURNAL OF BIOLOGICAL CHEMISTRY, 291(18), 9513-9525. doi:10.1074/jbc.M115.684308.


Cite as: https://hdl.handle.net/21.11116/0000-0001-C06D-C
Abstract
Heterotrimeric G proteins play an essential role in the initiation of G protein-coupled receptor (GPCR) signaling through specific interactions with a variety of cellular effectors. We have recently reported that GPCR activation promotes a direct interaction between G alpha q and protein kinase C zeta (PKC zeta), leading to the stimulation of the ERK5 pathway independent of the canonical effector PLC beta. We report herein that the activation-dependent G alpha q/PKC zeta complex involves the basic PB1-type II domain of PKC zeta and a novel interaction module in G alpha q different from the classical effector-binding site. Point mutations in this G alpha q region completely abrogate ERK5 phosphorylation, indicating that G alpha q/PKC zeta association is required for the activation of the pathway. Indeed, PKC zeta was demonstrated to directly bind ERK5 thus acting as a scaffold between G alpha q and ERK5 upon GPCR activation. The inhibition of these protein complexes by G protein-coupled receptor kinase 2, a known G alpha q modulator, led to a complete abrogation of ERK5 stimulation. Finally, we reveal that G alpha q/PKC zeta complexes link G alpha q to apoptotic cell death pathways. Our data suggest that the interaction between this novel region in G alpha q and the effector PKC zeta is a key event in G alpha q signaling.